This Article Extract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

(Circulation Research. 2007;101:e1.)
© 2007 American Heart Association, Inc.

Correction

In an article by Lee et al (Circ Res. 2007;100:372–380), the authors regrettably supplied an incorrectly loaded gel for tubulin for Figure 3 panel A. The corrected figure appears here.

View larger version (53K): [in this window] [in a new window]   Figure 3. FOXO3a blocked angiotensin II–induced CYR61 expression. A, Serial immunoblot analysis of CYR61, phosphorylated (thus inactivated) native FOXO3a and total native FOXO3a after angiotensin II (10–7 mol/L) stimulation. B, Serial immunoblot analysis of CYR61 protein at 2, 4, and 6 hours after angiotensin II stimulation. C, Corresponding immunohistochemistry of FOXO3a and CYR61 2 hours after angiotensin II stimulation in rat aorta that were pretransfected with Ad-GFP (left), Ad-TM-FOXO3a (middle), and Ad-antisense-FOXO3a (right), respectively. Effective transfection of Ad-TM-FOXO3a and Ad-GFP to rat aorta was confirmed by staining for HA, whereas Ad-antisense-FOXO3a does not contain sequences for HA.

This Article Extract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content